Current Drug Metabolism
Volume 20, 14 Issues, 2019
ISSN: 1875-5453 (Online)
ISSN: 1389-2002 (Print)
This journal supports open access
ISSN: 1875-5453 (Online)
ISSN: 1389-2002 (Print)
This journal supports open access
Ranking and Category
-
200th of 298 in
Biochemistry & Molecular Biology
-
158th of 267 in
Pharmacology & Pharmacy
Contents
Current Drug Metabolism, Volume 15 - Number 5
Editorial
Editorial (Thematic Issue: Chemoinformatics in Metabolomics, From Molecular Mechanics, Dynamics, and Docking to Complex Metabolic Networks, Part 2)
, 15(5): 489Humberto Gonzalez-Diaz, Alejandro Speck-Planche and Maria Natalia Dias Soeiro Cordeiro
DOI: 10.2174/138920021505141126101922
State of the Art and Development of a Drug-Drug Interaction Large Scale Predictor Based on 3D Pharmacophoric Similarity
, 15(5): 490 - 501Santiago Vilar, Eugenio Uriarte, Lourdes Santana, Carol Friedman and Nicholas P. Tatonetti
DOI: 10.2174/138920021505141126102223
Research/Review: Insights into the Mutation-Induced Dysfunction of Arachidonic Acid Metabolism from Modeling of Human CYP2J2
, 15(5): 502 - 513Xiao-Le Xia, Bo-Tao Fa, Shan Cong, Jing-Fang Wang and Kuo-Chen Chou
DOI: 10.2174/1389200215666140908095647
In silico Prediction of Drug Metabolism by P450
, 15(5): 514 - 525Carolina H. Andrade, Diego C. Silva and Rodolpho C. Braga
DOI: 10.2174/1389200215666140908102530
Research/Review: Structure and Linkage Disequilibrium Analysis of Adamantane Resistant Mutations in Influenza Virus M2 Proton Channel
, 15(5): 526 - 534Yao Yu, Xuan Li, Pei Hao, Jing-Fang Wang and Kuo-Chen Chou
DOI: 10.2174/1389200215666140605130406
Review and Research Analysis of Computational Target Methods Using BioRuby and In silico Screening of Herbal Lead Compounds Against Pancreatic Cancer Using R Programming
, 15(5): 535 - 543Jayadeepa R.M, Ankita Ray, Dhaval Naik, Debendra Nath Sanyal and Disha Shah
DOI: 10.2174/138920021505141126103546
Review and Research on Feature Selection Methods from NMR Data in Biological Fluids. Presentation of an Original Ensemble Method Applied to Atherosclerosis Field
, 15(5): 544 - 556Nabil Semmar, Cecile Canlet, Bernadette Delplanque, Pascale Le Ruyet, Alain Paris and Jean-Charles Martin
DOI: 10.2174/1389200215666140505152333
Galvez-Markov Network Transferability Indices: Review of Classic Theory and New Model for Perturbations in Metabolic Reactions
, 15(5): 557 - 564Jorge Vergara-Galicia, Francisco J. Prado-Prado and Humberto Gonzalez-Diaz
DOI: 10.2174/1389200215666140605125827
  |
Editor-in-Chief
Michael Sinz
Bristol Myers Squibb
Princeton, NJ
USA
Biography
View Full Editorial Board
Bristol Myers Squibb
Princeton, NJ
USA
Biography
Biography of Michael Sinz
Michael W. Sinz, Ph.D. is Director of Metabolism and Pharmacokinetics at Bristol Myers Squibb where he manages ADmezME lead optimization in drug discovery. Dr. Sinz previously held the position of Section Director-Pharmacokinetics and Drug Metabolism for Parke-Davis/Pfizer. He received B.S. degrees in Chemistry (ACS) and Biology from the University of Wisconsin-Eau Claire and a Ph.D. in Pharmacognosy/Medicinal Chemistry from the University of Minnesota (2001). He is editor in chief of Current Drug Metabolism and associate editor of Drug Metabolism Letters. Dr. Sinz’s resume includes an extensive number of peer reviewed publications, book chapters, and external presentations both locally and internationally.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Metabolism was launched in 2000. Dr. Michael Sinz serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net